Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system. - Archive ouverte HAL Access content directly
Journal Articles Journal of Biomedicine and Biotechnology Year : 2011

Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system.

(1) , (1) , (2) , (3) , (4) , (2) , (3) , (1) , (2, 5)
1
2
3
4
5

Abstract

The variety of recombinant protein expression systems have been developed as a resource of FVII gene expression. In the current study, the authors used a novel protein expression system based on the Iranian Lizard Leishmania, a trypanosomatid protozoan as a host for expression of FVII. Plasmid containing cDNA encoding full-length human FVII was introduced into Lizard Leishmania and positive transfectants were analyzed by SDS-PAGE and Western blot analysis. Furthermore, biological activity of purified protein was detected by PT assay. The recombinant strain harboring a construct was analyzed for expression of FVII at the mRNA and protein level. Purified rFVII was obtained and in order to confirm the purified compound was in fact rFVII. Western blot analysis was carried out. Clotting time in PT assay was reduced about 30 seconds with the purified rFVII. In Conclusion, this study has demonstrated, for the first time, that Leishmania cells can be used as an expression system for producing recombinant FVII.
Fichier principal
Vignette du fichier
873874.pdf (668.52 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

pasteur-00750784 , version 1 (12-11-2012)

Identifiers

Cite

Sina Mirzaahmadi, Golnaz Asaadi-Tehrani, Mojgan Bandehpour, Nooshin Davoudi, Leila Tahmasbi, et al.. Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system.. Journal of Biomedicine and Biotechnology, 2011, 2011, pp.873874. ⟨10.1155/2011/873874⟩. ⟨pasteur-00750784⟩

Collections

RIIP RIIP_IRAN
106 View
1164 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More